- Immuneering Corporation (IMRX) said on Tuesday it expects to be added to the Nasdaq Biotechnology Index, effective prior to the market open on December 22.
- The Nasdaq Biotechnology Index tracks the performance of biotechnology and pharmaceutical companies listed on Nasdaq and is reviewed annually in December based on eligibility criteria such as market capitalization and trading volume.
- TEVA +0.43% premarket to $30.26.
- Source: Press Release
Immuneering to be added to the Nasdaq Biotechnology Index
